1995
DOI: 10.1210/edrv-16-1-3
|View full text |Cite
|
Sign up to set email alerts
|

Insulin-Like Growth Factors and Their Binding Proteins: Biological Actions*

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

57
2,464
7
72

Year Published

1998
1998
2012
2012

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 2,497 publications
(2,600 citation statements)
references
References 0 publications
57
2,464
7
72
Order By: Relevance
“…The lack of a transmembrane anchor may affect its effectiveness as a dominant-negative inhibitor because there are a family of secreted IGF-binding proteins (insulin-like growth factor binding proteins), which bind IGFs with equal or even greater affinity than the IGF1R. 3,[28][29][30] IGFBPs are present at high levels in specific embryonic tissues and could potentially outcompete a dominant-negative IGF1R that does not contain an appropriate membrane anchor, thereby reducing the knockdown efficacy in those tissues.…”
Section: Discussionmentioning
confidence: 99%
“…The lack of a transmembrane anchor may affect its effectiveness as a dominant-negative inhibitor because there are a family of secreted IGF-binding proteins (insulin-like growth factor binding proteins), which bind IGFs with equal or even greater affinity than the IGF1R. 3,[28][29][30] IGFBPs are present at high levels in specific embryonic tissues and could potentially outcompete a dominant-negative IGF1R that does not contain an appropriate membrane anchor, thereby reducing the knockdown efficacy in those tissues.…”
Section: Discussionmentioning
confidence: 99%
“…These hypotheses suggests that obesity precipitates insulin resistance and the resulting prolonged hyperinsulinaemia in Obesity, overweight and cancer GD Batty et al itself acts as a tumour growth promoter. 44 Additionally, higher levels of insulin-like growth factor (IGF-I)Fa multifunctional, circulating peptide that encourages tumour growth through its mitosis and antiapoptosis properties 45 Fare positively associated with prostate and colorectal cancer risk, 46 both energy-related malignancies. While IGF-I is also positively related to BMI, the gradient is in fact nonlinear (at obese levels it decreases).…”
Section: Plausible Mechanismsmentioning
confidence: 99%
“…Insulin has the ability to stimulate IGFs which are important mitogens, necessary for the cell to progress from G1 to the S phase of the cell cycle (Aaronson, 1991). Ninety-five percent of IGF-1 circulates bound to IGF binding protein-3 (IGFBP-3), which controls the availability of free IGF-1 by modulating its access to the IGF-1 receptor (Jones & Clemmons, 1995;Collett-Solberg & Cohen 1996). IGF-1 promotes cell growth by stimulating tyrosine-specific protein kinase activity both in its own receptors as well as in the insulin receptors.…”
Section: Glycemic Index In Chronic Disease Ls Augustin Et Almentioning
confidence: 99%